Cowa, LLC Astrazeneca PLC Transaction History

Cowa, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$61.89 - $69.28 $247,560 - $277,120	-4,000 Reduced 55.56%	3,200 $216 Million
Q3 2023 Oct 30, 2023	SELL	$64.85 - $71.7 $89,492 - $98,946	-1,380 Reduced 16.08%	7,200 $488 Million
Q2 2023 Jul 25, 2023	SELL	$69.91 - $75.81 $2.42 Million - $2.62 Million	-34,555 Reduced 80.11%	8,580 $614 Million
Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $2.17 Million - $2.47 Million	34,435 Added 395.8%	43,135 $2.99 Million
Q4 2022 Jan 27, 2023	SELL	$54.21 - $70.44 $55,294 - $71,848	-1,020 Reduced 10.49%	8,700 $0
Q3 2022 Nov 04, 2022	BUY	$53.02 - $135.75 $58,322 - $149,325	1,100 Added 12.76%	9,720 $534,000
Q4 2021 Feb 04, 2022	BUY	$54.02 - $63.83 $5,402 - $6,383	100 Added 1.17%	8,620 $502,000
Q3 2021 Oct 22, 2021	SELL	$55.56 - $60.79 $25,002 - $27,355	-450 Reduced 5.02%	8,520 $512,000
Q2 2021 Aug 02, 2021	BUY	$48.42 - $60.18 $20,336 - $25,275	420 Added 4.91%	8,970 $541,000
Q1 2021 May 05, 2021	BUY	$47.16 - $54.44 $54,705 - $63,150	1,160 Added 15.7%	8,550 $427,000
Q4 2020 Feb 05, 2021	BUY	$48.52 - $58.02 $358,562 - $428,767	7,390 New	7,390 $375,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cowa, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowa, LLC with notifications on news.